Establishment Labs (NASDAQ:ESTA) Shares Up 6% – What’s Next?

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s stock price traded up 6% on Wednesday . The stock traded as high as $46.50 and last traded at $45.88. 31,734 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 385,023 shares. The stock had previously closed at $43.28.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ESTA shares. Stephens upgraded Establishment Labs to a “strong-buy” rating in a research report on Monday, December 2nd. Citigroup lifted their target price on Establishment Labs from $45.00 to $50.00 and gave the company a “neutral” rating in a research report on Tuesday, October 1st. Finally, BTIG Research upped their price objective on Establishment Labs from $62.00 to $65.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. One analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $60.60.

Establishment Labs Trading Down 0.2 %

The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The company has a fifty day moving average of $43.61 and a 200-day moving average of $44.21.

Institutional Trading of Establishment Labs

Large investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Establishment Labs by 11.8% in the first quarter. Vanguard Group Inc. now owns 77,798 shares of the company’s stock valued at $3,960,000 after buying an additional 8,210 shares in the last quarter. California State Teachers Retirement System grew its stake in shares of Establishment Labs by 14.5% during the 1st quarter. California State Teachers Retirement System now owns 17,096 shares of the company’s stock valued at $870,000 after buying an additional 2,167 shares during the period. SG Americas Securities LLC acquired a new position in shares of Establishment Labs in the 2nd quarter valued at about $303,000. Stableford Capital II LLC lifted its holdings in shares of Establishment Labs by 36.6% during the 2nd quarter. Stableford Capital II LLC now owns 42,102 shares of the company’s stock valued at $2,001,000 after acquiring an additional 11,287 shares in the last quarter. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in shares of Establishment Labs during the second quarter worth about $373,000. 72.91% of the stock is owned by institutional investors and hedge funds.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.